Literature DB >> 14726975

Cirrhosis and bacterial infections.

Hendrik Vilstrup1.   

Abstract

Half of cirrhosis patients die within two years after diagnosis, in most cases from cirrhosis related causes; most frequently variceal bleeding closely followed by infections. There seems to exist associations between infection and other complications such as malnutrition, hepatic encephalopathy and variceal bleeding. Cirrhosis patients have an acquired immune deficiency because of dyshomeostasis and malnutrition. All host defence systems are compromised, e.g. the acute phase response, and macrophage, neutrocyte, and lymphocyte functions. Simultaneously, there is increased microbiotic invasion, due to increased nosocomial exposure, intestinal translocation, aspiration, skin lesions, and trauma. Compared to the background population, the mortality of infections is more than 20 times increased in cirrhosis. The incidence of peritonitis, bacteremia, urinary tract infection, pneumonia, meningitis, tuberculosis, liver abscess is increased more than tenfold, and the mortality of each episode 3-10 times higher. The systemic response and accompanying classical symptoms are usually weakened. When positive isolates can be obtained the flora tends to be of an opportunistic nature. Infection should be suspected in any cirrhotic patient with an unexpected deterioration of clinical course. Treatment should be started on suspicion and with large dose broad-spectrum antibiotics (avoiding aminoglycosides). Antibiotic prophylaxis is efficacious at variceal bleeding, recurrent peritonitis, and at very low protein ascites, but otherwise is associated with risk of infection with multi-resistant strains.

Entities:  

Mesh:

Year:  2003        PMID: 14726975

Source DB:  PubMed          Journal:  Rom J Gastroenterol        ISSN: 1221-4167


  15 in total

Review 1.  Gut flora and bacterial translocation in chronic liver disease.

Authors:  John Almeida; Sumedha Galhenage; Jennifer Yu; Jelica Kurtovic; Stephen M Riordan
Journal:  World J Gastroenterol       Date:  2006-03-14       Impact factor: 5.742

Review 2.  Reprint of: Nutrition in the Management of Cirrhosis and its Neurological Complications.

Authors:  Chantal Bémeur; Roger F Butterworth
Journal:  J Clin Exp Hepatol       Date:  2015-02-19

3.  A retrospective study of bacterial infections in cirrhosis.

Authors:  Carmen Monica Preda; Ruxandra Ghita; Camelia Ghita; Cezarina Mindru; Livia Vlaicu; Adriana Andrei; Sorin Andrei; Mircea Diculescu
Journal:  Maedica (Bucur)       Date:  2011-07

Review 4.  Nutrition in the management of cirrhosis and its neurological complications.

Authors:  Chantal Bémeur; Roger F Butterworth
Journal:  J Clin Exp Hepatol       Date:  2013-06-11

5.  A randomized controlled trial of thymalfasin plus transarterial chemoembolization for unresectable hepatocellular carcinoma.

Authors:  Robert G Gish; Stuart C Gordon; David Nelson; Vinod Rustgi; Israel Rios
Journal:  Hepatol Int       Date:  2009-05-08       Impact factor: 6.047

Review 6.  Fatal Enterococcus durans aortic valve endocarditis: a case report and review of the literature.

Authors:  Rajakrishnan Vijayakrishnan; Alwyn Rapose
Journal:  BMJ Case Rep       Date:  2012-06-08

7.  Chronic systemic endotoxin exposure: an animal model in experimental hepatic encephalopathy.

Authors:  Kai O Lindros; Harri A Järveläinen
Journal:  Metab Brain Dis       Date:  2005-12       Impact factor: 3.584

8.  Impact of Hepatitis C Virus/Schistosoma mansoni Coinfection on the Circulating Levels of HCV-NS4 Protein and Extracellular-Matrix Deposition in Patients with Different Hepatic Fibrosis Stages.

Authors:  Abdelfattah M Attallah; Sanaa O Abdallah; Mohamed S Albannan; Mohamed M Omran; Ahmed A Attallah; Khaled Farid
Journal:  Am J Trop Med Hyg       Date:  2016-08-15       Impact factor: 2.345

Review 9.  Innate immune dysfunction in acute and chronic liver disease.

Authors:  Bettina Leber; Ursula Mayrhauser; Michael Rybczynski; Vanessa Stadlbauer
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

10.  Effects of hepatocyte CD14 upregulation during cholestasis on endotoxin sensitivity.

Authors:  Ming-Huei Chou; Jiin-Haur Chuang; Hock-Liew Eng; Po-Chin Tsai; Chih-Sung Hsieh; Hsiang-Chun Liu; Chiou-Huey Wang; Chih-Yun Lin; Tsun-Mei Lin
Journal:  PLoS One       Date:  2012-04-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.